[Event Report] Making the ‘Silent Pandemic’ of AMR Heard: What Countries Leading the Charge Against AMR are Doing to Ensure their Populations are Protected (April 28, 2022)
date : 11/28/2022
Tags: AMR
*The report of this symposium has been published. (November 28, 2022)
On April 28, 2022, AMR Alliance Japan (Secretariat: Health and Global Policy Institute) held a symposium gathering experts from Japan and other countries that are leading the way in the fight against AMR. Participants from Japan, Germany, the United Kingdom, and the United States discussed each country’s AMR response, and possibilities for future collaborations in this space.
This symposium shared international best practices for stronger policy responses against AMR as well as trends of policy discussions on this issue. Moving forward, AMR Alliance Japan and HGPI will continue to work to make the ‘silent pandemic’ of AMR heard.
[Overview]
- Date and time: April 28, 2022; 18:00-19:30, JST
- Format: Online using the Zoom conferencing system
- Host: AMR Alliance Japan / Health and Global Policy Institute (HGPI)
- Languages: English and Japanese (simultaneous interpretation will be provided)
- Participation fee: Free
[Program]
18:00-18:05 Welcome and Introduction
Matt McEnany (Senior Manager, Health and Global Policy Institute / AMR Alliance Japan)
18:05-18:10 Opening Remarks
Yasuhisa Shiozaki (Former Member, House of Representatives / Member, WHO Global Leaders Group on Antimicrobial Resistance)
18:10-18:20 – Looking Back on the UK’s G7 Presidency – Future Plans for AMR Policy
Sally Davies (UK Special Envoy on Antimicrobial Resistance / Member, WHO Global Leaders Group on Antimicrobial Resistance)
18:20-18:30 – AMR in Germany’s G7 Presidency
Dagmar Reitenbach (Head of Division Global Health, Federal Ministry of Health (BMG), Germany)
18:30-18:40 – AMR Policy Priorities in the United States and Across Europe
Kevin Outterson (Executive Director, CARB-X)
18:40-18:50 – Japanese Leadership on AMR Countermeasures
Norio Ohmagari (Director, Department of Infectious Diseases, National Center for Global Health and Medicine / Director, AMR Clinical Reference Center, National Center for Global Health and Medicine)
18:50 – 19:30 Panel Discussion / Q&A
Panelists
- Sally Davies (UK Special Envoy on Antimicrobial Resistance / Member, WHO Global Leaders Group on Antimicrobial Resistance)
- Dagmar Reitenbach (Head of Division Global Health, Federal Ministry of Health (BMG), Germany)
- Kevin Outterson (Executive Director, CARB-X)
- Norio Ohmagari (Director, Department of Infectious Diseases, National Center for Global Health and Medicine / Director, AMR Clinical Reference Center, National Center for Global Health and Medicine)
- Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Moderator
Matt McEnany (Senior Manager, Health and Global Policy Institute / AMR Alliance Japan)
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] “International comparison of dementia policies, research study on information dissemination.” (April 10, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-26
[Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
-
2024-05-01
[Registration Open] The Global Health Education Program (G-HEP) 2024 (May 1, 2024)
-
2024-05-02
[Announcement] Recruitment of the Health Policy Academy the 13th Session